This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB03914/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03914/identifier/pubchem-compound/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03914/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03914/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03914
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03914 n13:DB03914
dcterms:title
[2-(1-Amino-2-Hydroxy-Propyl)-4-(1h-Indol-3-Ylmethylene)-5-Oxo-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde
adms:identifier
n8:46508442 n9:CRF n10:46936828 n11:DB03914
n3:IUPAC-Name
n4:271B4F3B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4F41-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4F40-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4F3D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4F3E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4F3F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4F39-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4F37-363D-11E5-9242-09173F13E4C5 n4:271B4F3A-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4F38-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4F47-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4F48-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4F42-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4F43-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4F45-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4F44-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4F46-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4F4D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4F4F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4F50-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4F4C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4F4B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4F4E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4F3C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4F49-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4F4A-363D-11E5-9242-09173F13E4C5